{
 "about": "Medicines whose official non-proprietary name differs between countries: the WHO International Nonproprietary Name (INN), the US name (USAN, or the USP title where there is no USAN), and the British approved name (BAN) or a former BAN. One row per INN, each with the official source(s) that show the pair and the date checked. Names only.",
 "checked": "2026-09-23",
 "systems": {
  "inn": "WHO International Nonproprietary Name",
  "usan": "US name: the United States Adopted Name (usBasis \"USAN\"); where GSRS tags no USAN, the US Pharmacopeia monograph title (usBasis \"USP\"), else the name FDA uses, when GSRS shows it as the record's preferred name and Drugs@FDA lists it as an active ingredient (usBasis \"FDA\")",
  "ban": "British approved name that the UK kept when it moved to rINNs in 2003 (adrenaline, noradrenaline)",
  "formerBan": "Former British approved name, replaced in the UK by the rINN from 1 December 2003"
 },
 "leftOut": "A pair no official source shows. Japanese Accepted Names (JAN). Salt-only differences.",
 "build": "tools/build-names.cjs",
 "rows": [
{"inn":"acenocoumarol","formerBan":"nicoumalone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Nicoumalone; rINN (new BAN) Acenocoumarol"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists acenocoumarol (the list is written in INNs)"}]},
{"inn":"aciclovir","usan":"acyclovir","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): Acyclovir (UNII X4HES1O11F)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/d23f2d02-8ec6-4b64-aba3-ee5819f66be5","checked":"2026-09-23","shows":"INN tag: aciclovir; USAN tag: acyclovir"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists aciclovir (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists ACYCLOVIR as an active ingredient"}]},
{"inn":"alimemazine","usan":"trimeprazine","usBasis":"FDA","formerBan":"trimeprazine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Trimeprazine; rINN (new BAN) Alimemazine"},{"title":"FDA Global Substance Registration System (GSRS): TRIMEPRAZINE (UNII 76H78MJJ52)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/c9bbb3fb-7a98-435a-8ca3-306851749ad5","checked":"2026-09-23","shows":"INN tag: alimemazine; FDA preferred name of the record: trimeprazine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists TRIMEPRAZINE as an active ingredient"}]},
{"inn":"amfetamine","usan":"amphetamine","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Amphetamine (UNII CK833KGX7E)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/d18472dd-4bc9-4255-ab23-0625d8640252","checked":"2026-09-23","shows":"INN tag: amfetamine; FDA preferred name of the record: amphetamine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists AMPHETAMINE as an active ingredient"}]},
{"inn":"amobarbital","formerBan":"amylobarbitone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Amylobarbitone; rINN (new BAN) Amobarbital"}]},
{"inn":"amobarbital sodium","formerBan":"amylobarbitone sodium","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Amylobarbitone sodium; rINN (new BAN) Amobarbital sodium"}]},
{"inn":"amoxicillin","formerBan":"amoxycillin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Amoxycillin; rINN (new BAN) Amoxicillin"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists amoxicillin (the list is written in INNs)"}]},
{"inn":"articaine","formerBan":"carticaine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Carticaine; rINN (new BAN) Articaine"}]},
{"inn":"beclometasone","usan":"beclomethasone","usBasis":"FDA","formerBan":"beclomethasone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Beclomethasone; rINN (new BAN) Beclometasone"},{"title":"FDA Global Substance Registration System (GSRS): BECLOMETHASONE (UNII KGZ1SLC28Z)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/149462aa-1468-425b-955f-41874daa7783","checked":"2026-09-23","shows":"INN tag: beclometasone; FDA preferred name of the record: beclomethasone"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists beclometasone (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists BECLOMETHASONE as an active ingredient"}]},
{"inn":"bendroflumethiazide","usan":"bendroflumethiazide","usBasis":"USP","formerBan":"bendrofluazide","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Bendrofluazide; rINN (new BAN) Bendroflumethiazide"},{"title":"FDA Global Substance Registration System (GSRS): BENDROFLUMETHIAZIDE (UNII 5Q52X6ICJI)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/9cf8f038-36e5-421f-82f6-e27f209a0beb","checked":"2026-09-23","shows":"INN tag: bendroflumethiazide; USP monograph tag: bendroflumethiazide"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists BENDROFLUMETHIAZIDE as an active ingredient"}]},
{"inn":"benorilate","formerBan":"benorylate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Benorylate; rINN (new BAN) Benorilate"}]},
{"inn":"benzatropine","usan":"benztropine","usBasis":"FDA","formerBan":"benztropine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Benztropine; rINN (new BAN) Benzatropine"},{"title":"FDA Global Substance Registration System (GSRS): BENZTROPINE (UNII 1NHL2J4X8K)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/7d345cd2-dcc5-49e0-b01c-be2bf6058a8b","checked":"2026-09-23","shows":"INN tag: benzatropine; FDA preferred name of the record: benztropine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists BENZTROPINE as an active ingredient"}]},
{"inn":"benzylpenicillin","usan":"penicillin g","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Penicillin G (UNII Q42T66VG0C)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/17f4c6e4-d578-4f58-87ce-572324ec1838","checked":"2026-09-23","shows":"INN tag: benzylpenicillin; FDA preferred name of the record: penicillin g"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists benzylpenicillin (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists PENICILLIN G as an active ingredient"}]},
{"inn":"busulfan","usan":"busulfan","usBasis":"USP","formerBan":"busulphan","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Busulphan; rINN (new BAN) Busulfan"},{"title":"FDA Global Substance Registration System (GSRS): Busulfan (UNII G1LN9045DK)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/cca0a8b1-1e96-4ecc-b129-1777d102022f","checked":"2026-09-23","shows":"INN tag: busulfan; USP monograph tag: busulfan"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists BUSULFAN as an active ingredient"}]},
{"inn":"butobarbital","formerBan":"butobarbitone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Butobarbitone; rINN (new BAN) Butobarbital"}]},
{"inn":"calcitonin salmon","formerBan":"salcatonin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Salcatonin; rINN (new BAN) Calcitonin (salmon)"}]},
{"inn":"cefalexin","formerBan":"cephalexin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Cephalexin; rINN (new BAN) Cefalexin"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists cefalexin (the list is written in INNs)"}]},
{"inn":"cefalotin","usan":"cephalothin","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Cephalothin (UNII R72LW146E6)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/15c06547-2c92-4a4b-89fe-6df8d41b417d","checked":"2026-09-23","shows":"INN tag: cefalotin; FDA preferred name of the record: cephalothin"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CEPHALOTHIN as an active ingredient"}]},
{"inn":"cefamandole nafate","formerBan":"cephamandole nafate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Cephamandole Nafate; rINN (new BAN) Cefamandole Nafate"}]},
{"inn":"cefapirin","usan":"cephapirin","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): CEPHAPIRIN (UNII 89B59H32VN)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/c8c7ae5f-b06c-4ea5-8eb1-8248c496eeb9","checked":"2026-09-23","shows":"INN tag: cefapirin; FDA preferred name of the record: cephapirin"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CEPHAPIRIN as an active ingredient"}]},
{"inn":"cefazolin","usan":"cefazolin","usBasis":"USP","formerBan":"cephazolin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Cephazolin; rINN (new BAN) Cefazolin"},{"title":"FDA Global Substance Registration System (GSRS): Cefazolin (UNII IHS69L0Y4T)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/8276051a-ea8a-4fef-9f8b-2bae7005133d","checked":"2026-09-23","shows":"INN tag: cefazolin; USP monograph tag: cefazolin"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists cefazolin (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CEFAZOLIN as an active ingredient"}]},
{"inn":"cefradine","formerBan":"cephradine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Cephradine; rINN (new BAN) Cefradine"}]},
{"inn":"chlormethine","usan":"mechlorethamine","usBasis":"FDA","formerBan":"mustine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Mustine; rINN (new BAN) Chlormethine"},{"title":"FDA Global Substance Registration System (GSRS): MECHLORETHAMINE (UNII 50D9XSG0VR)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/56ae73a8-c975-4f2e-acaa-c468ff4ad26a","checked":"2026-09-23","shows":"INN tag: chlormethine; FDA preferred name of the record: mechlorethamine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists MECHLORETHAMINE as an active ingredient"}]},
{"inn":"chlorobutanol","formerBan":"chlorbutol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Chlorbutol; rINN (new BAN) Chlorobutanol"}]},
{"inn":"chlorphenamine","usan":"chlorpheniramine","usBasis":"FDA","formerBan":"chlorpheniramine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Chlorpheniramine; rINN (new BAN) Chlorphenamine"},{"title":"FDA Global Substance Registration System (GSRS): Chlorpheniramine (UNII 3U6IO1965U)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/7c197b6e-e419-460a-89b7-8cc1068639ae","checked":"2026-09-23","shows":"INN tag: chlorphenamine; FDA preferred name of the record: chlorpheniramine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CHLORPHENIRAMINE as an active ingredient"}]},
{"inn":"chlortalidone","usan":"chlorthalidone","usBasis":"USAN","formerBan":"chlorthalidone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Chlorthalidone; rINN (new BAN) Chlortalidone"},{"title":"FDA Global Substance Registration System (GSRS): Chlorthalidone (UNII Q0MQD1073Q)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/037629b5-dbb2-4d39-9091-2b06aaeda7e3","checked":"2026-09-23","shows":"INN tag: chlortalidone; USAN tag: chlorthalidone"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists chlortalidone (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CHLORTHALIDONE as an active ingredient"}]},
{"inn":"ciclosporin","usan":"cyclosporine","usBasis":"USAN","formerBan":"cyclosporin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Cyclosporin; rINN (new BAN) Ciclosporin"},{"title":"FDA Global Substance Registration System (GSRS): Cyclosporine (UNII 83HN0GTJ6D)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/2017927d-5141-48f8-848d-6c1b26165593","checked":"2026-09-23","shows":"INN tag: ciclosporin; USAN tag: cyclosporine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists ciclosporin (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CYCLOSPORINE as an active ingredient"}]},
{"inn":"cinchocaine","usan":"dibucaine","usBasis":"USP","sources":[{"title":"FDA Global Substance Registration System (GSRS): Dibucaine (UNII L6JW2TJG99)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/870dc588-25e4-4362-bc74-95f6452b569b","checked":"2026-09-23","shows":"INN tag: cinchocaine; USP monograph tag: dibucaine"}]},
{"inn":"clomethiazole","formerBan":"chlormethiazole","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Chlormethiazole; rINN (new BAN) Clomethiazole"}]},
{"inn":"clomifene","usan":"clomiphene","usBasis":"FDA","formerBan":"clomiphene","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Clomiphene; rINN (new BAN) Clomifene"},{"title":"FDA Global Substance Registration System (GSRS): CLOMIPHENE (UNII 1HRS458QU2)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/ee3158f4-8e67-45aa-bd13-75d84370946b","checked":"2026-09-23","shows":"INN tag: clomifene; FDA preferred name of the record: clomiphene"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists clomifene (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CLOMIPHENE as an active ingredient"}]},
{"inn":"cloral betaine","usan":"chloral betaine","usBasis":"USAN","formerBan":"chloral betaine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Chloral betaine; rINN (new BAN) Cloral betaine"},{"title":"FDA Global Substance Registration System (GSRS): CHLORAL BETAINE (UNII 8680278NRH)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/cd92c72c-7bd5-45b3-8e4d-292a709068d2","checked":"2026-09-23","shows":"INN tag: cloral betaine; USAN tag: chloral betaine"}]},
{"inn":"colecalciferol","usan":"cholecalciferol","usBasis":"USP","formerBan":"cholecalciferol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Cholecalciferol; rINN (new BAN) Colecalciferol"},{"title":"FDA Global Substance Registration System (GSRS): Cholecalciferol (UNII 1C6V77QF41)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/fb131ef1-dd0b-45ba-a50e-e6a2ea49aa3c","checked":"2026-09-23","shows":"INN tag: colecalciferol; USP monograph tag: cholecalciferol"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists colecalciferol (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CHOLECALCIFEROL as an active ingredient"}]},
{"inn":"colestyramine","usan":"cholestyramine resin","usBasis":"USP","formerBan":"cholestyramine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Cholestyramine; rINN (new BAN) Colestyramine"},{"title":"FDA Global Substance Registration System (GSRS): Cholestyramine (UNII 4B33BGI082)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/72f6fe0b-f0d6-47c1-ac3b-ae3503f79306","checked":"2026-09-23","shows":"INN tag: colestyramine; USP monograph tag: cholestyramine resin"}]},
{"inn":"colistimethate sodium","usan":"colistimethate sodium","usBasis":"USAN","formerBan":"colistin sulphomethate sodium","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Colistin Sulphomethate Sodium; rINN (new BAN) Colistimethate Sodium"},{"title":"FDA Global Substance Registration System (GSRS): COLISTIMETHATE SODIUM (UNII XW0E5YS77G)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/06f80712-0687-4359-b618-c8db8478a3cd","checked":"2026-09-23","shows":"INN tag: colistimethate sodium; USAN tag: colistimethate sodium"}]},
{"inn":"corticotropin","formerBan":"corticotrophin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Corticotrophin; rINN (new BAN) Corticotropin"}]},
{"inn":"cromoglicic acid","usan":"cromolyn","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Cromolyn (UNII Y0TK0FS77W)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/c2e7390b-9591-46da-ab60-9dce0e9de96a","checked":"2026-09-23","shows":"INN tag: cromoglicic acid; FDA preferred name of the record: cromolyn"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CROMOLYN as an active ingredient"}]},
{"inn":"dantron","formerBan":"danthron","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Danthron; rINN (new BAN) Dantron"}]},
{"inn":"desoximetasone","usan":"desoximetasone","usBasis":"USAN","formerBan":"desoxymethasone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Desoxymethasone; rINN (new BAN) Desoximetasone"},{"title":"FDA Global Substance Registration System (GSRS): DESOXIMETASONE (UNII 4E07GXB7AU)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/72b16562-1670-4983-b193-328353174be5","checked":"2026-09-23","shows":"INN tag: desoximetasone; USAN tag: desoximetasone"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists DESOXIMETASONE as an active ingredient"}]},
{"inn":"dexamfetamine","usan":"dextroamphetamine","usBasis":"USAN","formerBan":"dexamphetamine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Dexamphetamine; rINN (new BAN) Dexamfetamine"},{"title":"FDA Global Substance Registration System (GSRS): Dextroamphetamine (UNII TZ47U051FI)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/5011382e-879d-4a4e-9307-46621a7d0a53","checked":"2026-09-23","shows":"INN tag: dexamfetamine; USAN tag: dextroamphetamine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists DEXTROAMPHETAMINE as an active ingredient"}]},
{"inn":"dibrompropamidine","formerBan":"dibromopropamidine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Dibromopropamidine; rINN (new BAN) Dibrompropamidine"}]},
{"inn":"dicycloverine","usan":"dicyclomine","usBasis":"FDA","formerBan":"dicyclomine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Dicyclomine; rINN (new BAN) Dicycloverine"},{"title":"FDA Global Substance Registration System (GSRS): DICYCLOMINE (UNII 4KV4X8IF6V)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/7ad42c02-f1dc-4205-9f3f-1dbae5955579","checked":"2026-09-23","shows":"INN tag: dicycloverine; FDA preferred name of the record: dicyclomine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists DICYCLOMINE as an active ingredient"}]},
{"inn":"dienestrol","formerBan":"dienoestrol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Dienoestrol; rINN (new BAN) Dienestrol"}]},
{"inn":"diethylstilbestrol","usan":"diethylstilbestrol","usBasis":"USP","formerBan":"stilboestrol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Stilboestrol; rINN (new BAN) Diethylstilbestrol"},{"title":"FDA Global Substance Registration System (GSRS): DIETHYLSTILBESTROL (UNII 731DCA35BT)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/43d6d8c0-d32a-41f0-bb72-4f92ee01672a","checked":"2026-09-23","shows":"INN tag: diethylstilbestrol; USP monograph tag: diethylstilbestrol"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists DIETHYLSTILBESTROL as an active ingredient"}]},
{"inn":"dimethyl sulfoxide","usan":"dimethyl sulfoxide","usBasis":"USAN","formerBan":"dimethyl sulphoxide","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Dimethyl sulphoxide; rINN (new BAN) Dimethyl sulfoxide"},{"title":"FDA Global Substance Registration System (GSRS): Dimethyl sulfoxide (UNII YOW8V9698H)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/1441fe5c-93b2-4678-b647-5792916d353a","checked":"2026-09-23","shows":"INN tag: dimethyl sulfoxide; USAN tag: dimethyl sulfoxide"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists DIMETHYL SULFOXIDE as an active ingredient"}]},
{"inn":"dimeticone","usan":"dimethicone","usBasis":"USAN","formerBan":"dimethicone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Dimethicone; rINN (new BAN) Dimeticone"},{"title":"FDA Global Substance Registration System (GSRS): DIMETHICONE, UNSPECIFIED (UNII 92RU3N3Y1O)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/830de39a-5dc0-4e25-8e07-bee304decb37","checked":"2026-09-23","shows":"INN tag: dimeticone; USAN tag: dimethicone"}]},
{"inn":"dipotassium clorazepate","usan":"clorazepate dipotassium","usBasis":"USAN","formerBan":"potassium clorazepate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Potassium Clorazepate; rINN (new BAN) Dipotassium Clorazepate"},{"title":"FDA Global Substance Registration System (GSRS): Clorazepate Dipotassium (UNII 63FN7G03XY)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/161cd258-8508-43b9-90a6-253bf375a04f","checked":"2026-09-23","shows":"INN tag: dipotassium clorazepate; USAN tag: clorazepate dipotassium"}]},
{"inn":"dosulepin","formerBan":"dothiepin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Dothiepin; rINN (new BAN) Dosulepin"}]},
{"inn":"epinephrine","usan":"epinephrine","usBasis":"USP","ban":"adrenaline","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"adrenaline (rINN epinephrine) is one of the two exceptions: the UK keeps the BAN adrenaline"},{"title":"FDA Global Substance Registration System (GSRS): Epinephrine (UNII YKH834O4BH)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/bcc0057b-8ef0-47d3-9049-2b5ef6f2c6c7","checked":"2026-09-23","shows":"INN tag: epinephrine; USP monograph tag: epinephrine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists epinephrine (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists EPINEPHRINE as an active ingredient"}]},
{"inn":"estradiol","usan":"estradiol","usBasis":"USP","formerBan":"oestradiol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Oestradiol; rINN (new BAN) Estradiol"},{"title":"FDA Global Substance Registration System (GSRS): Estradiol (UNII 4TI98Z838E)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/dbe30db9-e2f7-42a1-897d-344c3d8f9272","checked":"2026-09-23","shows":"INN tag: estradiol; USP monograph tag: estradiol"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists estradiol (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists ESTRADIOL as an active ingredient"}]},
{"inn":"estriol","formerBan":"oestriol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Oestriol; rINN (new BAN) Estriol"}]},
{"inn":"estrone","usan":"estrone","usBasis":"USP","formerBan":"oestrone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Oestrone; rINN (new BAN) Estrone"},{"title":"FDA Global Substance Registration System (GSRS): ESTRONE (UNII 2DI9HA706A)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/9fd0b249-e7f5-4ecb-8c5d-0e403e9d2da7","checked":"2026-09-23","shows":"INN tag: estrone; USP monograph tag: estrone"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists ESTRONE as an active ingredient"}]},
{"inn":"etacrynic acid","usan":"ethacrynic acid","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): Ethacrynic Acid (UNII M5DP350VZV)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/867524b8-dbb1-4552-9d8f-df68e824b27e","checked":"2026-09-23","shows":"INN tag: etacrynic acid; USAN tag: ethacrynic acid"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists ETHACRYNIC ACID as an active ingredient"}]},
{"inn":"etamsylate","usan":"ethamsylate","usBasis":"USAN","formerBan":"ethamsylate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Ethamsylate; rINN (new BAN) Etamsylate"},{"title":"FDA Global Substance Registration System (GSRS): Ethamsylate (UNII 24YL531VOH)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/3bdd7973-379b-490b-a335-c69e23df541f","checked":"2026-09-23","shows":"INN tag: etamsylate; USAN tag: ethamsylate"}]},
{"inn":"ethinylestradiol","usan":"ethinyl estradiol","usBasis":"USP","formerBan":"ethinyloestradiol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Ethinyloestradiol; rINN (new BAN) Ethinylestradiol"},{"title":"FDA Global Substance Registration System (GSRS): ETHINYL ESTRADIOL (UNII 423D2T571U)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/5ad05fae-0e42-4ab4-8276-17f02baaeb05","checked":"2026-09-23","shows":"INN tag: ethinylestradiol; USP monograph tag: ethinyl estradiol"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists ethinylestradiol (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists ETHINYL ESTRADIOL as an active ingredient"}]},
{"inn":"etynodiol","formerBan":"ethynodiol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Ethynodiol; rINN (new BAN) Etynodiol"}]},
{"inn":"fludroxycortide","usan":"flurandrenolide","usBasis":"USAN","formerBan":"flurandrenolone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Flurandrenolone; rINN (new BAN) Fludroxycortide"},{"title":"FDA Global Substance Registration System (GSRS): FLURANDRENOLIDE (UNII 8EUL29XUQT)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/1dbe0277-3dd3-4de1-a222-56da4fc12977","checked":"2026-09-23","shows":"INN tag: fludroxycortide; USAN tag: flurandrenolide"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists FLURANDRENOLIDE as an active ingredient"}]},
{"inn":"flumetasone","usan":"flumethasone","usBasis":"USAN","formerBan":"flumethasone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Flumethasone; rINN (new BAN) Flumetasone"},{"title":"FDA Global Substance Registration System (GSRS): Flumethasone (UNII LR3CD8SX89)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/768f393e-d050-467d-ac6b-22f8dc4b4983","checked":"2026-09-23","shows":"INN tag: flumetasone; USAN tag: flumethasone"}]},
{"inn":"flupentixol","formerBan":"flupenthixol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Flupenthixol; rINN (new BAN) Flupentixol"}]},
{"inn":"formoterol","formerBan":"eformoterol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Eformoterol; rINN (new BAN) Formoterol"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists formoterol (the list is written in INNs)"}]},
{"inn":"furosemide","usan":"furosemide","usBasis":"USAN","formerBan":"frusemide","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Frusemide; rINN (new BAN) Furosemide"},{"title":"FDA Global Substance Registration System (GSRS): Furosemide (UNII 7LXU5N7ZO5)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/34aee01f-75c2-43eb-a78e-795668929e92","checked":"2026-09-23","shows":"INN tag: furosemide; USAN tag: furosemide"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists furosemide (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists FUROSEMIDE as an active ingredient"}]},
{"inn":"gestonorone","formerBan":"gestronol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Gestronol; rINN (new BAN) Gestonorone"}]},
{"inn":"glibenclamide","usan":"glyburide","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): Glyburide (UNII SX6K58TVWC)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/16a7b4a3-68d3-4153-9d29-ff2f1ea073df","checked":"2026-09-23","shows":"INN tag: glibenclamide; USAN tag: glyburide"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists glibenclamide (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists GLYBURIDE as an active ingredient"}]},
{"inn":"glycopyrronium bromide","usan":"glycopyrrolate","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): Glycopyrrolate (UNII V92SO9WP2I)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/0285b104-bf9b-4ed0-83b6-d4b840416c5a","checked":"2026-09-23","shows":"INN tag: glycopyrronium bromide; USAN tag: glycopyrrolate"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists GLYCOPYRROLATE as an active ingredient"}]},
{"inn":"guaifenesin","usan":"guaifenesin","usBasis":"USAN","formerBan":"guaiphenesin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Guaiphenesin; rINN (new BAN) Guaifenesin"},{"title":"FDA Global Substance Registration System (GSRS): Guaifenesin (UNII 495W7451VQ)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/bf7e8975-9043-46f6-90a8-f365a9eedbfc","checked":"2026-09-23","shows":"INN tag: guaifenesin; USAN tag: guaifenesin"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists GUAIFENESIN as an active ingredient"}]},
{"inn":"hexachlorophene","usan":"hexachlorophene","usBasis":"USP","formerBan":"hexachlorophane","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Hexachlorophane; rINN (new BAN) Hexachlorophene"},{"title":"FDA Global Substance Registration System (GSRS): HEXACHLOROPHENE (UNII IWW5FV6NK2)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/5001ad3b-e1e5-401f-968b-40b532245294","checked":"2026-09-23","shows":"INN tag: hexachlorophene; USP monograph tag: hexachlorophene"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists HEXACHLOROPHENE as an active ingredient"}]},
{"inn":"hydroxycarbamide","usan":"hydroxyurea","usBasis":"USAN","formerBan":"hydroxyurea","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Hydroxyurea; rINN (new BAN) Hydroxycarbamide"},{"title":"FDA Global Substance Registration System (GSRS): HYDROXYCARBAMIDE (UNII X6Q56QN5QC)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/fbb32702-c540-40d0-9cff-eff39554c9e9","checked":"2026-09-23","shows":"INN tag: hydroxycarbamide; USAN tag: hydroxyurea"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists hydroxycarbamide (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists HYDROXYUREA as an active ingredient"}]},
{"inn":"indometacin","usan":"indomethacin","usBasis":"USAN","formerBan":"indomethacin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Indomethacin; rINN (new BAN) Indometacin"},{"title":"FDA Global Substance Registration System (GSRS): Indomethacin (UNII XXE1CET956)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/36bb067c-6dfc-4a3a-b81f-19f15a5ebb5a","checked":"2026-09-23","shows":"INN tag: indometacin; USAN tag: indomethacin"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists indometacin (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists INDOMETHACIN as an active ingredient"}]},
{"inn":"isoprenaline","usan":"isoproterenol","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): ISOPROTERENOL (UNII L628TT009W)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/aa391a5c-5366-40cf-be9d-c06e58158b4d","checked":"2026-09-23","shows":"INN tag: isoprenaline; FDA preferred name of the record: isoproterenol"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists ISOPROTERENOL as an active ingredient"}]},
{"inn":"levomepromazine","usan":"levomepromazine","usBasis":"USAN","formerBan":"methotrimeprazine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Methotrimeprazine; rINN (new BAN) Levomepromazine"},{"title":"FDA Global Substance Registration System (GSRS): LEVOMEPROMAZINE (UNII 9G0LAW7ATQ)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/198d4e56-82fd-4c63-ad74-c6f1e920132c","checked":"2026-09-23","shows":"INN tag: levomepromazine; USAN tag: levomepromazine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists LEVOMEPROMAZINE as an active ingredient"}]},
{"inn":"levosalbutamol","usan":"levalbuterol","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Levalbuterol (UNII EDN2NBH5SS)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/38cffb0e-8411-40a3-950d-8773957bbab7","checked":"2026-09-23","shows":"INN tag: levosalbutamol; FDA preferred name of the record: levalbuterol"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists LEVALBUTEROL as an active ingredient"}]},
{"inn":"levothyroxine sodium","formerBan":"thyroxine sodium","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Thyroxine Sodium; rINN (new BAN) Levothyroxine Sodium"}]},
{"inn":"lidocaine","usan":"lidocaine","usBasis":"USP","formerBan":"lignocaine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Lignocaine; rINN (new BAN) Lidocaine"},{"title":"FDA Global Substance Registration System (GSRS): Lidocaine (UNII 98PI200987)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/087f7c29-e973-41b7-889e-7952d8b02364","checked":"2026-09-23","shows":"INN tag: lidocaine; USP monograph tag: lidocaine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists lidocaine (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists LIDOCAINE as an active ingredient"}]},
{"inn":"lisuride","formerBan":"lysuride","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Lysuride; rINN (new BAN) Lisuride"}]},
{"inn":"meclozine","usan":"meclizine","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Meclizine (UNII 3L5TQ84570)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/b40d71a3-fc63-4be7-8238-9ed0f84b07cf","checked":"2026-09-23","shows":"INN tag: meclozine; FDA preferred name of the record: meclizine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists MECLIZINE as an active ingredient"}]},
{"inn":"mecysteine","formerBan":"methyl cysteine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Methyl Cysteine; rINN (new BAN) Mecysteine"}]},
{"inn":"mercaptamine","usan":"cysteamine","usBasis":"USAN","formerBan":"cysteamine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Cysteamine; rINN (new BAN) Mercaptamine"},{"title":"FDA Global Substance Registration System (GSRS): CYSTEAMINE (UNII 5UX2SD1KE2)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/dc63a4fd-20b1-46d3-831c-e7261846932e","checked":"2026-09-23","shows":"INN tag: mercaptamine; USAN tag: cysteamine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists CYSTEAMINE as an active ingredient"}]},
{"inn":"mesalazine","usan":"mesalamine","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): MESALAMINE (UNII 4Q81I59GXC)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/86eb03a8-d07f-4462-aa45-7f7e95c33efc","checked":"2026-09-23","shows":"INN tag: mesalazine; USAN tag: mesalamine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists mesalazine (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists MESALAMINE as an active ingredient"}]},
{"inn":"metamfetamine","usan":"methamphetamine","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): METHAMPHETAMINE (UNII 44RAL3456C)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/c37be0b0-a940-4c71-9804-f2a23771ce61","checked":"2026-09-23","shows":"INN tag: metamfetamine; FDA preferred name of the record: methamphetamine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists METHAMPHETAMINE as an active ingredient"}]},
{"inn":"methenamine hippurate","formerBan":"hexamine hippurate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Hexamine Hippurate; rINN (new BAN) Methenamine Hippurate"}]},
{"inn":"methylergometrine","usan":"methylergonovine","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Methylergonovine (UNII W53L6FE61V)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/fe263be5-8824-4699-80b3-fdee7dfa6503","checked":"2026-09-23","shows":"INN tag: methylergometrine; FDA preferred name of the record: methylergonovine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists methylergometrine (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists METHYLERGONOVINE as an active ingredient"}]},
{"inn":"methylthioninium chloride","formerBan":"methylene blue","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Methylene Blue; rINN (new BAN) Methylthioninium Chloride"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists methylthioninium chloride (the list is written in INNs)"}]},
{"inn":"mitoxantrone","formerBan":"mitozantrone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Mitozantrone; rINN (new BAN) Mitoxantrone"}]},
{"inn":"moxisylyte","formerBan":"thymoxamine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Thymoxamine; rINN (new BAN) Moxisylyte"}]},
{"inn":"nitrofural","usan":"nitrofurazone","usBasis":"USP","sources":[{"title":"FDA Global Substance Registration System (GSRS): Nitrofurazone (UNII X8XI70B5Z6)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/1fecb3ef-5ee1-40e3-8ad2-88a753a9c6e6","checked":"2026-09-23","shows":"INN tag: nitrofural; USP monograph tag: nitrofurazone"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists NITROFURAZONE as an active ingredient"}]},
{"inn":"norepinephrine","ban":"noradrenaline","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"noradrenaline (rINN norepinephrine) is one of the two exceptions: the UK keeps the BAN noradrenaline"}]},
{"inn":"norethisterone","usan":"norethindrone","usBasis":"USP","sources":[{"title":"FDA Global Substance Registration System (GSRS): Norethindrone (UNII T18F433X4S)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/03872652-fe65-4845-88fa-fa35a5189a59","checked":"2026-09-23","shows":"INN tag: norethisterone; USP monograph tag: norethindrone"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists norethisterone (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists NORETHINDRONE as an active ingredient"}]},
{"inn":"orciprenaline","usan":"metaproterenol","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Metaproterenol (UNII 53QOG569E0)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/de233b1c-c0b8-413d-bbf3-c728959093ce","checked":"2026-09-23","shows":"INN tag: orciprenaline; FDA preferred name of the record: metaproterenol"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists METAPROTERENOL as an active ingredient"}]},
{"inn":"oxetacaine","usan":"oxethazaine","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): OXETHAZAINE (UNII IP8QT76V17)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/b372f33f-114f-4315-a1db-0caa55073c8e","checked":"2026-09-23","shows":"INN tag: oxetacaine; USAN tag: oxethazaine"}]},
{"inn":"paracetamol","usan":"acetaminophen","usBasis":"USP","sources":[{"title":"FDA Global Substance Registration System (GSRS): Acetaminophen (UNII 362O9ITL9D)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/405063af-a864-4615-a28d-9aca37b0ec74","checked":"2026-09-23","shows":"INN tag: paracetamol; USP monograph tag: acetaminophen"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists paracetamol (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists ACETAMINOPHEN as an active ingredient"}]},
{"inn":"pentoxifylline","usan":"pentoxifylline","usBasis":"USAN","formerBan":"oxpentifylline","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Oxpentifylline; rINN (new BAN) Pentoxifylline"},{"title":"FDA Global Substance Registration System (GSRS): Pentoxifylline (UNII SD6QCT3TSU)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/8b111192-4481-4559-b7d5-13bdca3d1a9a","checked":"2026-09-23","shows":"INN tag: pentoxifylline; USAN tag: pentoxifylline"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists PENTOXIFYLLINE as an active ingredient"}]},
{"inn":"pethidine","usan":"meperidine","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Meperidine (UNII 9E338QE28F)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/92fbe18b-5a2e-430c-ac63-ddec80e3de5b","checked":"2026-09-23","shows":"INN tag: pethidine; FDA preferred name of the record: meperidine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists MEPERIDINE as an active ingredient"}]},
{"inn":"phenobarbital","usan":"phenobarbital","usBasis":"USP","formerBan":"phenobarbitone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Phenobarbitone; rINN (new BAN) Phenobarbital"},{"title":"FDA Global Substance Registration System (GSRS): Phenobarbital (UNII YQE403BP4D)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/59189426-490f-40e3-badd-a7006b740fcc","checked":"2026-09-23","shows":"INN tag: phenobarbital; USP monograph tag: phenobarbital"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists phenobarbital (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists PHENOBARBITAL as an active ingredient"}]},
{"inn":"phenoxymethylpenicillin","usan":"penicillin v","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): Penicillin V (UNII Z61I075U2W)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/8e6d3388-1d7e-48cf-bc33-e8ec0cc51b49","checked":"2026-09-23","shows":"INN tag: phenoxymethylpenicillin; USAN tag: penicillin v"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists phenoxymethylpenicillin (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists PENICILLIN V as an active ingredient"}]},
{"inn":"phytomenadione","usan":"phytonadione","usBasis":"USP","sources":[{"title":"FDA Global Substance Registration System (GSRS): PHYTONADIONE (UNII A034SE7857)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/ab11a3c6-ba16-47d2-a96b-645dac699736","checked":"2026-09-23","shows":"INN tag: phytomenadione; USP monograph tag: phytonadione"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists phytomenadione (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists PHYTONADIONE as an active ingredient"}]},
{"inn":"pipotiazine","formerBan":"pipothiazine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Pipothiazine; rINN (new BAN) Pipotiazine"}]},
{"inn":"polihexanide","usan":"polihexanide","usBasis":"USAN","formerBan":"polyhexanide","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Polyhexanide; rINN (new BAN) Polihexanide"},{"title":"FDA Global Substance Registration System (GSRS): POLIHEXANIDE (UNII 322U039GMF)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/b01ebc59-2724-4551-8bfc-69cd1bec9957","checked":"2026-09-23","shows":"INN tag: polihexanide; USAN tag: polihexanide"}]},
{"inn":"pramocaine","usan":"pramoxine","usBasis":"FDA","formerBan":"pramoxine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Pramoxine; rINN (new BAN) Pramocaine"},{"title":"FDA Global Substance Registration System (GSRS): PRAMOXINE (UNII 068X84E056)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/f8db396e-09ac-434d-85a1-53b22dd6af4f","checked":"2026-09-23","shows":"INN tag: pramocaine; FDA preferred name of the record: pramoxine"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists PRAMOXINE as an active ingredient"}]},
{"inn":"procaine benzylpenicillin","formerBan":"procaine penicillin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Procaine Penicillin; rINN (new BAN) Procaine Benzylpenicillin"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists procaine benzylpenicillin (the list is written in INNs)"}]},
{"inn":"protionamide","formerBan":"prothionamide","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Prothionamide; rINN (new BAN) Protionamide"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists protionamide (the list is written in INNs)"}]},
{"inn":"ribavirin","usan":"ribavirin","usBasis":"USAN","formerBan":"tribavirin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Tribavirin; rINN (new BAN) Ribavirin"},{"title":"FDA Global Substance Registration System (GSRS): RIBAVIRIN (UNII 49717AWG6K)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/63e3a2fd-1881-44bb-8d8d-469f6400ec4f","checked":"2026-09-23","shows":"INN tag: ribavirin; USAN tag: ribavirin"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists ribavirin (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists RIBAVIRIN as an active ingredient"}]},
{"inn":"riboflavin","usan":"riboflavin","usBasis":"USP","formerBan":"riboflavine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Riboflavine; rINN (new BAN) Riboflavin"},{"title":"FDA Global Substance Registration System (GSRS): Riboflavin (UNII TLM2976OFR)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/abb070a4-f562-435a-b95f-913ea099be53","checked":"2026-09-23","shows":"INN tag: riboflavin; USP monograph tag: riboflavin"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists riboflavin (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists RIBOFLAVIN as an active ingredient"}]},
{"inn":"rifampicin","usan":"rifampin","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): Rifampin (UNII VJT6J7R4TR)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/4fba4435-771e-4450-97e9-e141bbbc818e","checked":"2026-09-23","shows":"INN tag: rifampicin; USAN tag: rifampin"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists rifampicin (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists RIFAMPIN as an active ingredient"}]},
{"inn":"rosoxacin","usan":"rosoxacin","usBasis":"USAN","formerBan":"acrosoxacin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Acrosoxacin; rINN (new BAN) Rosoxacin"},{"title":"FDA Global Substance Registration System (GSRS): ROSOXACIN (UNII 3Y1OT3J4NW)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/38c4473b-211c-47af-bc98-2f39a9e46275","checked":"2026-09-23","shows":"INN tag: rosoxacin; USAN tag: rosoxacin"}]},
{"inn":"salbutamol","usan":"albuterol","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): Albuterol (UNII QF8SVZ843E)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/7e0fae4c-00c6-4453-a6dc-a60ce10141ae","checked":"2026-09-23","shows":"INN tag: salbutamol; USAN tag: albuterol"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists salbutamol (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists ALBUTEROL as an active ingredient"}]},
{"inn":"secobarbital","formerBan":"quinalbarbitone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Quinalbarbitone; rINN (new BAN) Secobarbital"}]},
{"inn":"sodium calcium edetate","formerBan":"sodium calciumedetate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sodium Calciumedetate; rINN (new BAN) Sodium Calcium Edetate"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists sodium calcium edetate (the list is written in INNs)"}]},
{"inn":"sodium cromoglicate","formerBan":"sodium cromoglycate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sodium Cromoglycate; rINN (new BAN) Sodium Cromoglicate"}]},
{"inn":"sodium feredetate","formerBan":"sodium ironedetate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sodium Ironedetate; rINN (new BAN) Sodium Feredetate"}]},
{"inn":"sodium picosulfate","formerBan":"sodium picosulphate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sodium Picosulphate; rINN (new BAN) Sodium Picosulfate"}]},
{"inn":"sodium stibocaptate","formerBan":"stibocaptate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Stibocaptate; rINN (new BAN) Sodium Stibocaptate"}]},
{"inn":"sorbitan stearate","usan":"sorbitan monostearate","usBasis":"USAN","formerBan":"sorbitan monostearate","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sorbitan Monostearate; rINN (new BAN) Sorbitan Stearate"},{"title":"FDA Global Substance Registration System (GSRS): SORBITAN MONOSTEARATE (UNII NVZ4I0H58X)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/24116b30-d329-4a33-b1d1-48d65f33db1c","checked":"2026-09-23","shows":"INN tag: sorbitan stearate; USAN tag: sorbitan monostearate"}]},
{"inn":"sulfacetamide","formerBan":"sulphacetamide","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sulphacetamide; rINN (new BAN) Sulfacetamide"}]},
{"inn":"sulfadiazine","usan":"sulfadiazine","usBasis":"USP","formerBan":"sulphadiazine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sulphadiazine; rINN (new BAN) Sulfadiazine"},{"title":"FDA Global Substance Registration System (GSRS): SULFADIAZINE (UNII 0N7609K889)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/b6b227c0-aeb0-45ab-bf3f-465af25ec64b","checked":"2026-09-23","shows":"INN tag: sulfadiazine; USP monograph tag: sulfadiazine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists sulfadiazine (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists SULFADIAZINE as an active ingredient"}]},
{"inn":"sulfamethoxazole","usan":"sulfamethoxazole","usBasis":"USAN","formerBan":"sulphamethoxazole","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sulphamethoxazole; rINN (new BAN) Sulfamethoxazole"},{"title":"FDA Global Substance Registration System (GSRS): Sulfamethoxazole (UNII JE42381TNV)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/0430384b-a445-4afb-9a34-beb393b2549c","checked":"2026-09-23","shows":"INN tag: sulfamethoxazole; USAN tag: sulfamethoxazole"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists sulfamethoxazole (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists SULFAMETHOXAZOLE as an active ingredient"}]},
{"inn":"sulfapyridine","usan":"sulfapyridine","usBasis":"USP","formerBan":"sulphapyridine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sulphapyridine; rINN (new BAN) Sulfapyridine"},{"title":"FDA Global Substance Registration System (GSRS): Sulfapyridine (UNII Y5V2N1KE8U)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/c733cd99-5dda-4642-a82a-efc5f35047e0","checked":"2026-09-23","shows":"INN tag: sulfapyridine; USP monograph tag: sulfapyridine"}]},
{"inn":"sulfasalazine","usan":"sulfasalazine","usBasis":"USAN","formerBan":"sulphasalazine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sulphasalazine; rINN (new BAN) Sulfasalazine"},{"title":"FDA Global Substance Registration System (GSRS): Sulfasalazine (UNII 3XC8GUZ6CB)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/c29a29ec-2f53-4604-90b8-b62b219b2860","checked":"2026-09-23","shows":"INN tag: sulfasalazine; USAN tag: sulfasalazine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists sulfasalazine (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists SULFASALAZINE as an active ingredient"}]},
{"inn":"sulfathiazole","usan":"sulfathiazole","usBasis":"USP","formerBan":"sulphathiazole","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sulphathiazole; rINN (new BAN) Sulfathiazole"},{"title":"FDA Global Substance Registration System (GSRS): Sulfathiazole (UNII Y7FKS2XWQH)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/073ce56b-06c7-49db-b887-dd0b2d82d539","checked":"2026-09-23","shows":"INN tag: sulfathiazole; USP monograph tag: sulfathiazole"}]},
{"inn":"sulfinpyrazone","formerBan":"sulphinpyrazone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Sulphinpyrazone; rINN (new BAN) Sulfinpyrazone"}]},
{"inn":"suxamethonium chloride","usan":"succinylcholine chloride","usBasis":"USAN","sources":[{"title":"FDA Global Substance Registration System (GSRS): Succinylcholine Chloride (UNII I9L0DDD30I)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/9609e33f-6655-4ab1-8a0d-bffe3ae68c7c","checked":"2026-09-23","shows":"INN tag: suxamethonium chloride; USAN tag: succinylcholine chloride"}]},
{"inn":"tetracaine","usan":"tetracaine","usBasis":"USP","formerBan":"amethocaine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Amethocaine; rINN (new BAN) Tetracaine"},{"title":"FDA Global Substance Registration System (GSRS): TETRACAINE (UNII 0619F35CGV)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/b78fc0df-04de-4eaf-b1ea-c76e2f4c483c","checked":"2026-09-23","shows":"INN tag: tetracaine; USP monograph tag: tetracaine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists tetracaine (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists TETRACAINE as an active ingredient"}]},
{"inn":"tetracosactide","usan":"cosyntropin","usBasis":"USAN","formerBan":"tetracosactrin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Tetracosactrin; rINN (new BAN) Tetracosactide"},{"title":"FDA Global Substance Registration System (GSRS): COSYNTROPIN (UNII 72YY86EA29)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/0303e570-4db9-4bb6-bc8b-116258d6e131","checked":"2026-09-23","shows":"INN tag: tetracosactide; USAN tag: cosyntropin"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists COSYNTROPIN as an active ingredient"}]},
{"inn":"thiamazole","usan":"methimazole","usBasis":"USP","formerBan":"methimazole","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Methimazole; rINN (new BAN) Thiamazole"},{"title":"FDA Global Substance Registration System (GSRS): Methimazole (UNII 554Z48XN5E)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/c1e14227-6b5c-4116-834f-293a1287acdb","checked":"2026-09-23","shows":"INN tag: thiamazole; USP monograph tag: methimazole"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists METHIMAZOLE as an active ingredient"}]},
{"inn":"thiopental","formerBan":"thiopentone","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Thiopentone; rINN (new BAN) Thiopental"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists thiopental (the list is written in INNs)"}]},
{"inn":"tiabendazole","usan":"thiabendazole","usBasis":"USAN","formerBan":"thiabendazole","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Thiabendazole; rINN (new BAN) Tiabendazole"},{"title":"FDA Global Substance Registration System (GSRS): Thiabendazole (UNII N1Q45E87DT)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/b928e681-67a2-46a1-87df-bcddc30ddbe0","checked":"2026-09-23","shows":"INN tag: tiabendazole; USAN tag: thiabendazole"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists THIABENDAZOLE as an active ingredient"}]},
{"inn":"tioguanine","formerBan":"thioguanine","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Thioguanine; rINN (new BAN) Tioguanine"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists tioguanine (the list is written in INNs)"}]},
{"inn":"trihexyphenidyl","formerBan":"benzhexol","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Benzhexol; rINN (new BAN) Trihexyphenidyl"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists trihexyphenidyl (the list is written in INNs)"}]},
{"inn":"urofollitropin","usan":"urofollitropin","usBasis":"USAN","formerBan":"urofollitrophin","sources":[{"title":"Scottish Executive Health Department, SEHD/CMO(2004)3: Change in names of certain medicinal substances (17 March 2004), with the UK list “Changing substance names from BANs to rINNs”","url":"https://www.publications.scot.nhs.uk/files/cmo-2004-03.pdf","checked":"2026-09-23","shows":"Former BAN Urofollitrophin; rINN (new BAN) Urofollitropin"},{"title":"FDA Global Substance Registration System (GSRS): Urofollitropin (UNII W9BB98U6HP)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/2de6f57e-2fb2-4efb-a66b-d64edc958c14","checked":"2026-09-23","shows":"INN tag: urofollitropin; USAN tag: urofollitropin"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists UROFOLLITROPIN as an active ingredient"}]},
{"inn":"valaciclovir","usan":"valacyclovir","usBasis":"FDA","sources":[{"title":"FDA Global Substance Registration System (GSRS): Valacyclovir (UNII MZ1IW7Q79D)","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/278a8092-eea4-44dd-992c-c9a0f7579805","checked":"2026-09-23","shows":"INN tag: valaciclovir; FDA preferred name of the record: valacyclovir"},{"title":"WHO Model List of Essential Medicines, 24th list (2025)","url":"https://www.who.int/publications/i/item/B09474","checked":"2026-09-23","shows":"Lists valaciclovir (the list is written in INNs)"},{"title":"FDA Drugs@FDA data (openFDA bulk file)","url":"https://download.open.fda.gov/drug/drugsfda/drug-drugsfda-0001-of-0001.json.zip","checked":"2026-09-23","shows":"FDA lists VALACYCLOVIR as an active ingredient"}]}
]
}